Primer on Cerebrovascular Diseases

Protein Kinases in Cerebral Ischemia

Introduction Protein kinases are key regulators of cell processes. Protein kinases are defined as enzymes that transfer a phosphate group onto an acceptor amino acid in a substrate protein. This process is called phosphorylation and can be reversed by phosphatases,…

Oxidative and Nitrosative Stress

Oxidative stress plays a critical role in cerebral ischemic injury and occurs when there is an overproduction of free radicals and reactive oxygen species (ROS) beyond the ability of a biologic system to neutralize their adverse effects. ROS include oxygen…

Excitotoxicity and Stroke

Introduction A long-standing goal of stroke research has been to elucidate the mechanisms responsible for the high vulnerability of brain tissue to hypoxic-ischemic insults. Understanding these mechanisms will aid the development of specific countermeasures that could be employed in the…

Mitochondrial Mechanisms During Ischemia and Reperfusion

Introduction The mitochondrion keeps a continuous workflow for oxidation of energy substances that are obtained from the blood to produce adenosine triphosphate (ATP) for cellular functions. Neural cells consume this energy derived from the ATP hydrolysis for maintaining ionic gradients…

The Neurovascular Unit

Acknowledgments The neurovascular unit concept was developed by the entire research community, not just any one single scientist. The author apologizes to many colleagues who could not be included as coauthors and whose work could not be cited, due to…

Mechanisms of Glial Death and Protection

Introduction Cerebrovascular diseases cause tissue damage to both gray and white matter, which contribute about half of the CNS volume and differ in structure and cellular composition. White matter exclusively contains axons and their glial cell partners including fibrous astrocytes,…

Drug Delivery to the Central Nervous System

Introduction The effective delivery of pharmaceutical agents into the central nervous system (CNS) still represents a significant challenge to modern drug delivery. Much of this can be attributed to the presence of the blood–brain barrier (BBB), which consists of a…